Literature DB >> 20739525

Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Baoling Ying1, Ann E Tollefson, William S M Wold.   

Abstract

We previously identified an adenovirus (Ad) protein named U exon protein (UXP) encoded by a leftward-strand (l-strand) transcription unit. Here we identify and characterize the UXP promoter. Primer extension and RNase protection assays mapped the transcription initiation site at 32 nucleotides upstream of the UXP gene initiation codon. A series of viral mutants with mutations at two putative inverted CCAAT (I-CCAAT) boxes and two E2F sites were generated. With mutants lacking the proximal I-CCAAT box, the UXP mRNA level decreased significantly to 30% of the Ad type 5 (Ad5) mRNA level as measured by quantitative reverse transcription-PCR. Decreased UXP was also observed by immunoblotting and immunofluorescence. UXP mRNA and protein levels were similar to those of Ad5 for mutants lacking the distal I-CCAAT box or both putative E2F sites. Ad DNA levels were similar in mutant- and wild-type Ad5-infected cells during the late stage of infection, strongly suggesting that the decreased UXP mRNA and protein from mutants lacking the proximal I-CCAAT box was due to decreased promoter activity. Electrophoretic mobility shift assays (EMSA) indicated that a cellular factor binds specifically to the proximal I-CCAAT box of the UXP promoter. An in vitro luciferase reporter assay demonstrated that basal promoter activity lies between bp -158 and +30 of the transcription initiation site. No E1A-mediated promoter transactivation was observed in 293 cells compared with A549 cells. Thus, we propose that there is a previously unidentified Ad5 promoter that drives expression of the UXP transcription unit. This promoter is embedded within the gene for fiber, and it contains a proximal I-CCAAT box critical for UXP mRNA transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739525      PMCID: PMC2953154          DOI: 10.1128/JVI.01338-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites.

Authors:  Y Suzuki; H Taira; T Tsunoda; J Mizushima-Sugano; J Sese; H Hata; T Ota; T Isogai; T Tanaka; S Morishita; K Okubo; Y Sakaki; Y Nakamura; A Suyama; S Sugano
Journal:  EMBO Rep       Date:  2001-05       Impact factor: 8.807

Review 3.  Functions and mechanisms of action of the adenovirus E3 proteins.

Authors:  Drew L Lichtenstein; Karoly Toth; Konstantin Doronin; Ann E Tollefson; William S M Wold
Journal:  Int Rev Immunol       Date:  2004 Jan-Apr       Impact factor: 5.311

Review 4.  The RNA polymerase II core promoter.

Authors:  Stephen T Smale; James T Kadonaga
Journal:  Annu Rev Biochem       Date:  2003-03-19       Impact factor: 23.643

Review 5.  Mechanisms of E3 modulation of immune and inflammatory responses.

Authors:  S P Fessler; F Delgado-Lopez; M S Horwitz
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

Review 6.  Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways.

Authors:  M Windheim; A Hilgendorf; H G Burgert
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

7.  Adenovirus late-phase infection is controlled by a novel L4 promoter.

Authors:  Susan J Morris; Gillian E Scott; Keith N Leppard
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

8.  YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter.

Authors:  Per S Holm; Stephan Bergmann; Karsten Jurchott; Hermann Lage; Karsten Brand; Axel Ladhoff; Klaus Mantwill; David T Curiel; Matthias Dobbelstein; Manfred Dietel; Bernd Gansbacher; Hans-Dieter Royer
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

9.  DNA synthesis-dependent relief of repression of transcription from the adenovirus type 2 IVa(2) promoter by a cellular protein.

Authors:  Wenying Huang; J Kiefer; D Whalen; S J Flint
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

10.  TRANSFAC: transcriptional regulation, from patterns to profiles.

Authors:  V Matys; E Fricke; R Geffers; E Gössling; M Haubrock; R Hehl; K Hornischer; D Karas; A E Kel; O V Kel-Margoulis; D-U Kloos; S Land; B Lewicki-Potapov; H Michael; R Münch; I Reuter; S Rotert; H Saxel; M Scheer; S Thiele; E Wingender
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  4 in total

1.  Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.

Authors:  Mallory A Turner; Sumit Middha; Sean E Hofherr; Michael A Barry
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

Review 2.  The adenovirus genome contributes to the structural stability of the virion.

Authors:  Bratati Saha; Carmen M Wong; Robin J Parks
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

3.  Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells.

Authors:  Bratati Saha; Robin J Parks
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

4.  Novel viral splicing events and open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts.

Authors:  Alexander M Price; Robert T Steinbock; Richard Lauman; Matthew Charman; Katharina E Hayer; Namrata Kumar; Edwin Halko; Krystal K Lum; Monica Wei; Angus C Wilson; Benjamin A Garcia; Daniel P Depledge; Matthew D Weitzman
Journal:  PLoS Pathog       Date:  2022-09-12       Impact factor: 7.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.